<DOC>
	<DOCNO>NCT00918749</DOCNO>
	<brief_summary>Randomized , multicenter , double-blind , double-dummy , active-controlled , parallel-design study approximately 201 postmenopausal woman . A subset subject ( approximately 102 ) also participate pharmacokinetic ( PK ) component study . Each subject randomize 1 3 treatment regimen 3 month .</brief_summary>
	<brief_title>Delayed Release ( DR ) Risedronate Compared Immediate Release ( IR ) Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>female , 45 80 year age , good general health postmenopausal ≥2 year , surgically naturally body mass index less equal 32 kg/m^2 screening use within 3 month prior , use 1 month time within 6 month : glucocorticoid , anabolic steroid , estrogen , selective estrogenreceptor modulators ( SERMs ) , estrogenrelated drug , progestin , calcitonin , vitamin D supplement ( &gt; 1200 IU per day ) , calcitriol , calcidiol , alfacalcidol dose , bisphosphonate . fluoride ( ≥10 mg/day ) , strontium ( ≥50 mg/day ) , parathyroid hormone , investigational bone active agent . allergic abnormal reaction bisphosphonates history cancer within 5 year , exclude squamous basal cell carcinoma 6 month remission positive pregnancy test depot injection &gt; 10,000 IU vitamin D previous 9 month . history GI disease require medication , history Crohn 's disease , ulcerative colitis , diverticular disease , polyp , surgery could change GI structure motility . history frequent diarrhea constipation require regular laxative use . history alcohol durg abuse , hyperparathyroidism , cancer previous 5 year , major surgery within 1 month prior screening , diabetes , uncontrolled hypertension , cardiovascular , hepatic , renal GI disease . active hyperthyroidism , osteomalacia , use anticonvulsant medication , allergic reaction bisphosphonates</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>